Friday, August 29th, 2025
Stock Profile: LNSR
LNSR Logo

LENSAR, Inc. (LNSR)

Market: NASD | Currency: USD

Address: 2800 Discovery Drive

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract Show more




📈 LENSAR, Inc. Historical Chart






📊 Statistics





💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for LENSAR, Inc.


DateReported EPS
2025-11-06 (estimated upcoming)-
2025-08-07-0.1
2025-05-08-0.06
2025-02-27-0.1
2024-11-07-0.09
2024-08-08-0.12
2024-05-09-0.19
2024-03-04-0.35
2023-11-09-0.28
2023-08-09-0.25
2023-05-15-0.4
2023-03-16-0.24
2022-11-09-0.39
2022-08-08-0.67
2022-05-09-0.67
2022-03-03-0.41
2021-11-08-0.65
2021-08-05-0.47
2021-05-05-0.56
2021-03-10-0.78




📰 Related News & Research


No related articles found for "lensar inc".